RecruitingNCT05500833

Multidimensional Characterization of Dyspnea in Children

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

400 participants

Start Date

Jan 26, 2023

Study Type

OBSERVATIONAL

Conditions

Dyspnea and Respiratory Insufficiency in Children

Summary

There is no specific tool existing to describe dyspnea in children in a multidimensional way. It has been shown in adult studies that multidimensional dyspnea evaluation scales are well correlated to quality of life and respiratory function impairments. The investigators hypothesis is that using multidimensional dyspnea evaluation scales could allow for a more systematic and precise evaluation of this symptom in children, thus improving management and follow-up of patients presenting with acute (asthma attack, infectious diseases) and chronic (cystic fibrosis, primary ciliary diskynesia, neuromuscular diseases) respiratory insufficiency.

Eligibility

Min Age: 6 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study better characterizes how children between 6 and 17 years old experience and describe shortness of breath (dyspnea) during acute or chronic respiratory conditions, to improve how doctors assess and treat it. You may be eligible if: - Your child is between 6 and 17 years old - Your child is experiencing respiratory complaints - Your child is followed or admitted at Trousseau Hospital's pediatric pulmonology department in France - For acute dyspnea: your child was hospitalized for an acute respiratory disease within the past 72 hours - For chronic dyspnea: your child has a chronic respiratory disease You may NOT be eligible if: - Your child has cognitive disorders that prevent them from using self-assessment scales - Your child refuses to participate - For chronic dyspnea studies: your child had an acute respiratory crisis in the 6 weeks before enrollment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMultidimentional observation scale (MDP)

Upon arriving to the hospital (for an hospitalization or a consultation), a trained and declared investigator will inform the patients and their parents of the study, orally and using a written information note. Participation to the study will also be proposed to under aged children in an adequate language and a specific information note will be handed to them. If they wish, they will have a 20 min reflexion time before deciding on participating to the study.One the patient is included, the study will unfold as follows. First, Evaluation of acute dyspnea: general data and dyspnea scores will be collected upon inclusion, and dyspnea score will be collected once again 30 min later, and subsequently one a day until the end of hospitalization (test-retest). Data from clinical examination and treatment modifications will also be collected daily. Second, Evaluation of chronic dyspnea: general data and dyspnea scores will be collected upon inclusion and 1 to 1.5h later

Locations(1)

Service de pneumologie pédiatrique, Hôpital Armand Trousseau

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05500833